Keyphrases
Schizophrenia
100%
Patients with Schizophrenia
43%
Schizophrenic Patients
40%
Healthy Controls
27%
Schizophrenia Spectrum Disorders
26%
First-episode Psychosis
26%
Psychosis
25%
At-risk Mental State
25%
Magnetic Resonance Imaging Study
21%
MRI Study
17%
Gray Matter
15%
Volume Reduction
13%
Magnetic Resonance Imaging
13%
Insular Cortex
13%
Schizotypal Disorder
12%
Clinical High Risk for Psychosis (CHR-P)
12%
Cognitive Function
11%
Bipolar Disorder
10%
Superior Temporal Gyrus
10%
Gray Matter Volume
9%
Japan
9%
Autism Spectrum Disorder
9%
Psychotic Disorders
9%
Adhesio Interthalamica
9%
Control Subjects
9%
Amygdala
9%
Voxel-based Morphometry
8%
Antipsychotics
8%
Major Depressive Disorder
7%
Structural Magnetic Resonance Imaging (sMRI)
7%
Orbitofrontal Cortex
7%
Negative Symptoms
7%
Heschl's Gyrus
6%
Pituitary Volume
6%
Cognitive Impairment
6%
Superior Temporal
6%
Olfactory Sulcus
6%
Dementia
6%
Japanese Population
6%
Individuals at Risk
6%
Chronic Schizophrenia
6%
Temporal Lobe
6%
Brain Regions
6%
Brain Morphology
6%
Hippocampus
6%
Morphological Changes
6%
Mismatch Negativity
6%
Planum Temporale
6%
Cavum Septi Pellucidi
5%
MK-801
5%
Sulcus
5%
Vulnerability
5%
Volumetric MRI
5%
Childhood Autism
5%
Functional Outcome
5%
Brain Gyrification
5%
Regional Cerebral Blood Flow (rCBF)
5%
Neuroscience
Magnetic Resonance Imaging
50%
Gyri
22%
Gray Matter
21%
Magnetic Resonance Imaging
21%
Cognitive Function
16%
Negative Syndrome
16%
Psychosis
14%
Schizotypal Disorder
14%
Schizophrenia Spectrum Disorder
14%
Superior Temporal Gyrus
13%
Bipolar Disorder
13%
Insular Cortex
13%
Cognitive Disorders
13%
Amygdala
12%
Typical Antipsychotic
12%
Gray Matter Volume
11%
Pervasive Developmental Disorder
11%
Hippocampus
10%
Schizophrenia
9%
Voxel-Based Morphometry
9%
Prefrontal Cortex
9%
Orbitofrontal Cortex
9%
Positive Syndrome
9%
Gyrification
8%
Major Depressive Disorder
8%
Antipsychotic
8%
Temporal Lobe
7%
Receptor
7%
Mismatch Negativity
7%
Electromagnetism
6%
Event-Related Potential
6%
Frontal Lobe
5%
Planum Temporale
5%
Lateral Ventricle
5%
Structural Magnetic Resonance Imaging
5%
Hemispheric Dominance
5%
Thalamus
5%